TELA - Tela Bio Inc Stock Price, Fair Value and News

$1.15+0.01 (+0.88%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TELA Price Action

Last 7 days

2.7%

Last 30 days

-16.1%

Last 90 days

-27.7%

Trailing 12 Months

-60.9%

TELA RSI Chart

TELA Valuation

Market Cap

46.4M

Price/Earnings (Trailing)

-1.19

Price/Sales (Trailing)

0.6

EV/EBITDA

-1.71

Price/Free Cashflow

-1.47

TELA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TELA Fundamentals

TELA Revenue

Revenue (TTM)

77.1M

Rev. Growth (Yr)

9.14%

Rev. Growth (Qtr)

2.44%

TELA Earnings

Earnings (TTM)

-39.0M

Earnings Growth (Yr)

17.06%

Earnings Growth (Qtr)

13.3%

TELA Profitability

EBT Margin

-50.69%

Return on Equity

-2.5K%

Return on Assets

-63.32%

Free Cashflow Yield

-67.9%

TELA Investor Care

Shares Dilution (1Y)

2.42%

Diluted EPS (TTM)

-0.83

TELA Alerts

1 major insider buys recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	71.2M	75.3M	77.1M	0
2024	63.1M	64.7M	68.6M	69.3M
2023	45.1M	49.2M	53.1M	58.5M
2022	31.8M	34.7M	38.2M	41.4M
2021	20.4M	24.4M	26.8M	29.5M
2020	15.9M	16.1M	17.4M	18.2M
2019	10.1M	11.9M	13.7M	15.4M
2018	0	0	6.3M	8.3M
2017	0	0	0	4.2M

Get all data in R, Python etc through our Historical Stock Data APIs

About Tela Bio Inc

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

CEO	Mr. Antony Koblish
WEBSITE	telabio.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	173

Tela Bio Inc Frequently Asked Questions

What is the ticker symbol for Tela Bio Inc? What does TELA stand for in stocks?

TELA is the stock ticker symbol of Tela Bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tela Bio Inc (TELA)?

As of Wed Dec 03 2025, market cap of Tela Bio Inc is 46.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TELA stock?

You can check TELA's fair value in chart for subscribers.

Is Tela Bio Inc a good stock to buy?

The fair value guage provides a quick view whether TELA is over valued or under valued. Whether Tela Bio Inc is cheap or expensive depends on the assumptions which impact Tela Bio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TELA.

What is Tela Bio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, TELA's PE ratio (Price to Earnings) is -1.19 and Price to Sales (PS) ratio is 0.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TELA PE ratio will change depending on the future growth rate expectations of investors.